Background: The novel direct oral anticoagulants (NOA), dabigatran (a thrombin inhibitor), rivaroxaban and apixaban (factor Xa inhibitors) have shown at least noninferiority compared to
Objective: A prior meta-analysis of reports published between 2000 and 2008 found that women were 30% less likely to receive IV rt-PA treatment for stroke than men; we updated this meta-analysis to de
Summary of bleeding-related adverse events with an incidence >1% in all patients and in those undergoing any type of surgery, hepatic, biliary, or pancreatic surgery; gastrointestinal surgeries; and c
